Filing exhibits
- 8-K Current report
- 99.01 Press Release of the Company, August 29, 2024
- 99.02 Two Clinical Trials of Bedtime Sublingual Cyclobenzaprine (TNX-102 SL)
- 99.03 Development of the Aurora Platform Trial Network
- 99.04 Integrating Automated High-throughput Scratch Assay and Cell Painting
- Download Excel data file
- View Excel data file
Table of Contents